Literature DB >> 17868756

Recent advances in the understanding and treatment of anxiety disorders.

Steven L Shearer1.   

Abstract

Anxiety disorders usually are chronic or recurrent disorders characterized by stress sensitivity and a fluctuating course. Both psychopharmacologic and cognitive-behavioral treatments are well-established, evidence-based treatments for panic disorder, social anxiety disorder, generalized anxiety disorder, and obsessive-compulsive disorder. Exposure-based behavioral treatment is well established as evidence-based treatment for specific phobias. Primary care physicians can make a significant impact on patients' lives by identifying and educating about anxiety disorders, directing patients to appropriate self-help resources, choosing evidence-based drug treatment when indicated, and making referrals for specialist care.

Entities:  

Mesh:

Year:  2007        PMID: 17868756     DOI: 10.1016/j.pop.2007.05.002

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  6 in total

1.  Moderate treadmill exercise rescues anxiety and depression-like behavior as well as memory impairment in a rat model of posttraumatic stress disorder.

Authors:  Gaurav Patki; Lumeng Li; Farida Allam; Naimesh Solanki; An T Dao; Karim Alkadhi; Samina Salim
Journal:  Physiol Behav       Date:  2014-03-19

2.  The role of duloxetine in the treatment of anxiety disorders.

Authors:  Domenico De Berardis; Nicola Serroni; Alessandro Carano; Marco Scali; Alessandro Valchera; Daniela Campanella; Alessandro D'Albenzio; Berardo Di Giuseppe; Francesco Saverio Moschetta; Rosa Maria Salerno; Filippo Maria Ferro
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

Review 3.  Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior.

Authors:  Melissa Malvaez; Ruth M Barrett; Marcelo A Wood; Carles Sanchis-Segura
Journal:  Mamm Genome       Date:  2009-09-30       Impact factor: 2.957

4.  Neurons in the amygdala with response-selectivity for anxiety in two ethologically based tests.

Authors:  Dong V Wang; Fang Wang; Jun Liu; Lu Zhang; Zhiru Wang; Longnian Lin
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

5.  Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.

Authors:  Kalai Naidu; Werdie C W van Staden; Mike van der Linde
Journal:  BMC Psychiatry       Date:  2014-06-05       Impact factor: 3.630

6.  SK2 potassium channel overexpression in basolateral amygdala reduces anxiety, stress-induced corticosterone secretion and dendritic arborization.

Authors:  R Mitra; D Ferguson; R M Sapolsky
Journal:  Mol Psychiatry       Date:  2009-02-10       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.